An in-depth look to SCINOPHARM TAIWAN LTD operating, investing, and financing activities

1789 free cash flow for Q3 24 is -23 M TWD. For 2023, 1789 free cash flow was -37.25 M TWD and operating cash flow was 231.18 M TWD.